Juan Andres
Director/Board Member at AVANTOR, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Mr. Juan Andres is an Independent Director at Evelo Biosciences, Inc., an Independent Director at Avantor, Inc. and a Chief Technical Operations & Quality Officer at Moderna, Inc. He is on the Board of Directors at Evelo Biosciences, Inc., Avantor, Inc. and Ring Therapeutics, Inc. Mr. Andres was previously employed as a Global Head-Technical Operations by Novartis AG and a VP-Pharmaceutical Manufacturing & Devices by Eli Lilly & Co. He received his graduate degree from Universida de Alcalá de Henares.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVANTOR, INC.
0.01% | 2023-05-10 | 39,903 ( 0.01% ) | 1 M $ | 2024-03-30 |
EVELO BIOSCIENCES, INC.
-.--% | 2023-06-07 | 0 ( -.--% ) | - $ | 2024-03-30 |
Juan Andres active positions
| Companies | Position | Start |
|---|---|---|
| AVANTOR, INC. | Director/Board Member | 2019-08-31 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of Juan Andres
| Companies | Position | End |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Director/Board Member | 2023-11-19 |
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| NOVARTIS AG | Chief Tech/Sci/R&D Officer | 2017-05-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2008-12-31 |
Training of Juan Andres
| Universida de Alcalá de Henares | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NOVARTIS AG | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| AVANTOR, INC. | Process Industries |
| MODERNA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Juan Andres
